Last reviewed · How we verify
NCT03350945
Application of Carbon Nanoparticles in Laparoscopic Colorectal Surgery
NA trial testing Device: tumor localization in Colorectal Tumor in 150 participants. Status unknown.
1 August 2019
Quick facts
| Lead sponsor | Aiguo, Lu |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 December 2017 |
| Primary completion | 1 August 2019 |
| Estimated completion | 31 December 2019 |
Drugs / interventions tested
- Device: tumor localization
Conditions studied
- Colorectal Tumor — all drugs for Colorectal Tumor →
Sponsor
Aiguo, Lu
Who can join
Adults 18 to 80, any sex, with Colorectal Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The project aims to evaluate the safety, effectiveness, accuracy and economy efficiency of the application of carbon nanoparticles for tumor localization and lymph nodes mapping in the laparoscopic coloectal surgery.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Nanotechnology in cancer diagnosis: progress, challenges and opportunities.
Zhang Y, Li M, Gao X, Chen Y, et al · · 2019 · cited 227× · PMID 31847897 · DOI 10.1186/s13045-019-0833-3 -
Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics.
Madamsetty VS, Mukherjee A, Mukherjee S. · · 2019 · cited 82× · PMID 31708785 · DOI 10.3389/fphar.2019.01264 -
A detailed insight of the tumor targeting using nanocarrier drug delivery system.
Batool S, Sohail S, Ud Din F, Alamri AH, et al · · 2023 · cited 56× · PMID 36866455 · DOI 10.1080/10717544.2023.2183815 -
Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies.
Bortot B, Mangogna A, Di Lorenzo G, Stabile G, et al · · 2023 · cited 34× · PMID 37202750 · DOI 10.1186/s12951-023-01926-y -
Nanoparticles applied to cancer immunoregulation.
Lopez-Campos F, Candini D, Carrasco E, Berenguer Francés MA. · · 2019 · cited 20× · PMID 30425606 · DOI 10.1016/j.rpor.2018.10.001 -
A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis.
Sharma S, Bhattacharya S, Joshi K, Singh S. · · 2023 · cited 9× · PMID 37650995 · DOI 10.1007/s00432-023-05331-8 -
Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancer.
Kumar A, Vaiphei KK, Singh N, Datta Chigurupati SP, et al · · 2024 · cited 6× · PMID 39105753 · DOI 10.1080/17435889.2024.2350356 -
The Role of Inorganic Nanomaterials in Overcoming Challenges in Colorectal Cancer Diagnosis and Therapy.
Wang J, Wang H, Zou F, Gu J, et al · · 2025 · cited 3× · PMID 40284405 · DOI 10.3390/pharmaceutics17040409
Verify or expand the search:
- PubMed search for NCT03350945
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Tumor
Currently open trials in the same condition.
- NCT06640166 — Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Co · Phase 2 · recruiting
- NCT05558436 — Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer · active not recruiting
- NCT04013152 — Clinical Database of Colorectal Robotic Surgery · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03350945 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aiguo, Lu
- Last refreshed: 22 November 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03350945.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing